TANNER PHARMA UK LIMITED
Get an alert when TANNER PHARMA UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2025-12-31
Overdue
Confirmation statement due
2026-11-18 (in 6mo)
Last made up 2025-11-04
Watchouts
Cash
£10M
-31.9% vs 2022
Net assets
£1M
-88% first positive since 2018
Employees
23
0% vs 2022
Profit before tax
-£9M
-113.9% vs 2022
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2025-12-31.
-
Audit opinion: Qualified
Latest auditor's report carried a non-clean opinion.
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · latest reflected 2023-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £382,812,000 | £13,417,000 | |
| Operating profit | — | — | — | — | £67,562,000 | -£10,045,000 | |
| Profit before tax | — | — | — | — | £67,697,000 | -£9,426,000 | |
| Net profit | — | — | — | — | £54,924,000 | -£7,553,000 | |
| Cash | £217,579 | — | — | — | £13,985,000 | £9,527,000 | |
| Total assets less current liabilities | -£1,168,684 | — | — | — | £8,587,000 | £1,034,000 | |
| Net assets | -£2,188,017 | — | — | — | £8,587,000 | £1,034,000 | |
| Equity | -£2,188,017 | -£804,000 | £38,005,000 | £28,867,000 | £8,587,000 | £1,034,000 | |
| Average employees | 15 | — | — | — | 23 | 23 | |
| Wages | — | — | — | — | £9,673,000 | £3,427,000 | |
| Directors' remuneration | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2022 → FY2023 · period ending 2023-12-31 vs 2022-12-31
-
Turnover
-96.5%
£382,812,000 £13,417,000
-
Cash
-31.9%
£13,985,000 £9,527,000
-
Net assets
-88%
£8,587,000 £1,034,000
first positive since 2018
-
Employees
0%
23 23
-
Operating profit
-114.9%
£67,562,000 -£10,045,000
-
Profit before tax
-113.9%
£67,697,000 -£9,426,000
-
Wages
-64.6%
£9,673,000 £3,427,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | 17.6% | -74.9% | |
| Net margin | — | — | — | — | 14.3% | -56.3% | |
| Return on capital employed | — | — | — | — | 786.8% | -971.5% | |
| Current ratio | — | — | — | — | 1.63x | 1.05x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Haines Watts High Wycombe Limited
- Audit opinion
- Qualified
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- TANNER PHARMA UK LIMITED · parent
- Tannerlac UK Limited 100%
- Tanner Pharma IE Limited 100%
- Tanner Pharma CH GmbH 100%
Significant events
- “The budget allocated by the UKHSA to the pandemic response will continue to wane as the global pandemic is brought under control.”
- “A claim has been brought against the company and an affiliate in the United States District Court, W.D. North Carolina, Charlotte Division by a contractual counterparty. The claim is at an early procedural stage and the defendants vigorously dispute the claim in its entirety and have sought to assert counterclaims and have asserted defenses.”
- “As a result of the end of the compulsory testing for Covid-19 following the end of the global pandemic, going forward, there is expected to be a significant fall in revenue due to the decreased demand for Covid-19 test kits.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOURNE, Raymond Fairbanks | Director | 2015-04-29 | Aug 1971 | American |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BRADSHAW, Jamie Nicholas | Director | 2015-04-29 | 2016-10-31 |
| TUOMEY, David Spencer | Director | 2015-04-29 | 2016-10-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Raymond Fairbanks Bourne | Individual | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 30 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-28 | DISS40 | gazette | Gazette filings brought up to date | |
| 2026-03-03 | GAZ1 | gazette | Gazette notice compulsory | |
| 2025-11-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-19 | AA | accounts | Accounts with accounts type group | |
| 2024-11-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-29 | AA | accounts | Accounts with accounts type group | |
| 2023-03-31 | AA | accounts | Accounts with accounts type group | |
| 2023-03-24 | DISS40 | gazette | Gazette filings brought up to date | |
| 2023-03-07 | GAZ1 | gazette | Gazette notice compulsory | |
| 2022-11-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-11-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-09-28 | AA | accounts | Accounts with accounts type total exemption full | |
| 2021-04-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-09-22 | AA | accounts | Accounts with accounts type total exemption full | |
| 2020-04-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2019-09-18 | AA | accounts | Accounts with accounts type total exemption full | |
| 2019-04-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2018-09-27 | AA | accounts | Accounts with accounts type total exemption full | |
| 2018-04-17 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.